Literature DB >> 16565510

Epigenetic instability and chromosomal instability in hepatocellular carcinoma.

Hiroto Katoh1, Tatsuhiro Shibata, Akiko Kokubu, Hidenori Ojima, Masashi Fukayama, Yae Kanai, Setsuo Hirohashi.   

Abstract

The aim of this study was to clarify the association between the epigenetic instability phenotype and the chromosomal instability phenotype in primary hepatocellular carcinoma (HCC). Sixty primary HCC tumors were examined. Methylation status for nine CpG islands (the p16, COX2, GSTP1, RASSF1A, E-cadherin, and APC gene promoters, and the MINT 1, 25, and 31 clones) was evaluated by methylation-specific polymerase chain reaction. Chromosomal structural alterations of these 60 HCC tumors were characterized in our previous study by using whole genomic array-based comparative genomic hybridization. We found that the epigenetic instability phenotype and the chromosomal instability phenotype are not mutually exclusive in hepatocarcinogenesis and that they do not show a simple cause-and-effect relationship. Hepatitis virus infection in the background liver was significantly associated with these instability phenotypes. Furthermore, we identified an epigenetic instability-dependent HCC that shows frequent epigenetic aberrations without chromosomal instability. It was noteworthy that epigenetic instability-positive and -negative HCCs displayed distinctive combinations of chromosomal structural alterations. In summary, by combined analyses of genetic and epigenetic aberration profiles in HCC, we obtained a comprehensive view of genomic alterations in hepatocarcinogenesis. Our results have clinical relevance because epigenetic instability-dependent HCCs may respond well to methylation inhibitory therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16565510      PMCID: PMC2216681          DOI: 10.2353/ajpath.2006.050989

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis.

Authors:  Y Kanai; S Ushijima; H Tsuda; M Sakamoto; S Hirohashi
Journal:  Cancer Lett       Date:  2000-01-01       Impact factor: 8.679

2.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

3.  Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

Authors:  Jung-Ok Lee; Hyun Jin Kwun; Jin Kyu Jung; Kyung Hee Choi; Do Sik Min; Kyung Lib Jang
Journal:  Oncogene       Date:  2005-10-06       Impact factor: 9.867

4.  Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.

Authors:  Hiroto Katoh; Tatsuhiro Shibata; Akiko Kokubu; Hidenori Ojima; Panayiotis Loukopoulos; Yae Kanai; Tomoo Kosuge; Masashi Fukayama; Tadashi Kondo; Michiie Sakamoto; Fumie Hosoda; Misao Ohki; Issei Imoto; Johji Inazawa; Setsuo Hirohashi
Journal:  J Hepatol       Date:  2005-07-05       Impact factor: 25.083

5.  Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.

Authors:  M Makos; B D Nelkin; R E Reiter; J R Gnarra; J Brooks; W Isaacs; M Linehan; S B Baylin
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

6.  Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.

Authors:  Y Kondo; Y Kanai; M Sakamoto; M Mizokami; R Ueda; S Hirohashi
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

Review 7.  DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications.

Authors:  M Toyota; F Itoh; K Imai
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

8.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.

Authors:  C A Eads; R V Lord; S K Kurumboor; K Wickramasinghe; M L Skinner; T I Long; J H Peters; T R DeMeester; K D Danenberg; P V Danenberg; P W Laird; K A Skinner
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

9.  Genetic instability in colorectal cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

10.  Hypermethylation of multiple genes in pancreatic adenocarcinoma.

Authors:  T Ueki; M Toyota; T Sohn; C J Yeo; J P Issa; R H Hruban; M Goggins
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

View more
  16 in total

Review 1.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

2.  Role of a novel CAR-induced gene, TUBA8, in hepatocellular carcinoma cell lines.

Authors:  Hiroki Kamino; Rick Moore; Masahiko Negishi
Journal:  Cancer Genet       Date:  2011-07

3.  DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.

Authors:  Qinghua Feng; Joshua E Stern; Stephen E Hawes; Hiep Lu; Mingjun Jiang; Nancy B Kiviat
Journal:  Exp Mol Pathol       Date:  2010-01-14       Impact factor: 3.362

Review 4.  Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma.

Authors:  William Matthew Puszyk; Thu Le Trinh; Sarah J Chapple; Chen Liu
Journal:  Lab Invest       Date:  2013-08-05       Impact factor: 5.662

5.  Building Classification Models with Combined Biomarker Tests: Application to Early Detection of Liver Cancer.

Authors:  Dion Chen; Surbhi Jain; Ying-Hsu Su; Wei Song
Journal:  J Stat Sci Appl       Date:  2017 May-Jun

6.  The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.

Authors:  Xiaoling Zhou; Nicholas C Popescu; George Klein; Stephan Imreh
Journal:  Cancer Genet Cytogenet       Date:  2007-08

7.  Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis.

Authors:  Xiaoli Wu; Sumit Sandhu; Zinnatun Nabi; Hao Ding
Journal:  Transgenic Res       Date:  2012-01-12       Impact factor: 2.788

8.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

9.  Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.

Authors:  Surbhi Jain; Sitong Chen; Kung-Chao Chang; Yih-Jyh Lin; Chi-Tan Hu; Batbold Boldbaatar; James P Hamilton; Selena Y Lin; Ting-Tsung Chang; Shun-Hua Chen; Wei Song; Stephen J Meltzer; Timothy M Block; Ying-Hsiu Su
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

10.  DNA methylation: potential biomarker in Hepatocellular Carcinoma.

Authors:  Way-Champ Mah; Caroline Gl Lee
Journal:  Biomark Res       Date:  2014-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.